Delivery Order SPE2DB22D3019-SPE2DB24FK3VB
Award Date
8/29/24
Potential Completion Date
8/30/24
Potential Value
$39K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $33,374.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract is a firm fixed-price Delivery Order with a completion date of November 27, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award, valued at $3,503.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of June 20, 2024 and is a Firm Fixed Price arrangement. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VRAYLAR 3 MG CAPSULE 30S. The contract has a total ceiling value of $3,940.43 and a period of performance through March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is part of a larger indefinite delivery contract (IDC) with DLA Troop Support...
This federal contract award, valued at $7,993.63, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award covers the delivery of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product, with a completion date of November 20, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of VRAYLAR 3 MG CAPSULE 30S. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $2,834.31 with a completion date of March 12, 2025. The contract is for a firm fixed price with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999...
This federal contract award, valued at $15,115.89, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VRAYLAR 3 MG CAPSULE 30S, a medical supply item, with a completion date of January 8, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award, valued at $3,205.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product, and has an ultimate completion date of November 6, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. No set-aside designation was used. AmerisourceBergen holds a significant...
This federal contract award, valued at $9,172.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $3,358.30 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VRAYLAR 3 MG CAPSULE 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This federal contract award, valued at $7,601.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, and has an ultimate completion date of February 20, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...